blenrep
glaxosmithkline (ireland) limited - belantamab mafodotin - myeloma multiplex - daganatellenes szerek - blenrep is indicated as monotherapy for the treatment of multiple myeloma in adult patients, who have received at least four prior therapies and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.
syncumar mite 1 mg tabletta
bausch health ireland ltd. - acenokumarol -
marfagen 1 mg tabletta
mylan ireland ltd. - warfarin -
marfagen 3 mg tabletta
mylan ireland ltd. - warfarin -
marfagen 5 mg tabletta
mylan ireland ltd. - warfarin -
marfarin 5 mg tabletta
viatris ltd. - warfarin -
marfarin 1 mg tabletta
viatris ltd. - warfarin -
marfarin 3 mg tabletta
viatris ltd. - warfarin -
k9 competition sterling silver conditioner
groomingcity "végelszámolás alatt" kft. - külsoleges oldat - kutya
k9 competition sterling silver shampoo
groomingcity "végelszámolás alatt" kft. - sampon - kutya